Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference

Rhea-AI Summary

On August 29, 2022, Conformis, Inc. (NASDAQ: CFMS) announced that CEO Mark Augusti and CFO Bob Howe will participate in the H.C. Wainwright & Co. 24^th Annual Global Investment Conference from September 12-14, 2022. This hybrid conference, held at the Lotte New York Palace Hotel, features leading growth companies across various sectors. Conformis will present virtually, with an on-demand video available on September 12 at 7:00 a.m. ET. Virtual one-on-one meetings with management can also be scheduled. A replay will be accessible on their website for 90 days.

BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in the H.C. Wainwright & Co. 24^th Annual Global Investment Conference.

The hybrid conference will take place September 12-14, 2022. The conference will be held at the Lotte New York Palace Hotel and will include virtual and in-person participation. Some of the best and most promising growth companies in life sciences, cryptocurrency/fintech, TMT, and cleantech are expected to participate.

• Conformis management will participate virtually via an on-demand presentation which will be available starting on September 12, 2022 at 7:00 a.m. ET.
• Link to CFMS Presentation Video

Conformis management will also be available for virtual one-on-one meetings throughout the conference. For more information about the conference or to schedule a one-on-one meeting with management, please contact your H.C. Wainwright representative or Conformis Investor Relations at ir@conformis.com and (781) 374-5598.

The replay of the presentation will be available under "Events and Presentations" in the Investors section of the Conformis website at ir.conformis.com. A replay of the webcast will be archived on Conformis' website for 90 days following the presentation.

About Conformis, Inc.

Founded in 2004, Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant® Platinum Services℠ Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box™ delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints. For more information, visit www.conformis.com. To receive future press releases via e-mail alerts, sign up at ir.conformis.com.

Investor Contact:
ir@conformis.com
(781) 374-5598

FAQ

What is the date of the H.C. Wainwright & Co. 24th Annual Global Investment Conference?

The conference is scheduled for September 12-14, 2022.

Who from Conformis will be attending the conference?

CEO Mark Augusti and CFO Bob Howe will represent Conformis at the conference.

How can I view Conformis’ presentation at the conference?

The presentation will be available on-demand starting September 12, 2022, at 7:00 a.m. ET.

Is there an option for one-on-one meetings with Conformis management during the conference?

Yes, one-on-one virtual meetings with management are available throughout the conference.

Where can I find the replay of Conformis' presentation?

The replay will be available under 'Events and Presentations' in the Investors section of Conformis' website for 90 days.